174 related articles for article (PubMed ID: 37475781)
1. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
[TBL] [Abstract][Full Text] [Related]
2. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
3. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
[TBL] [Abstract][Full Text] [Related]
4. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
[TBL] [Abstract][Full Text] [Related]
6. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
[TBL] [Abstract][Full Text] [Related]
7. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
8. Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications.
Ul Mustafa Z; Batool A; Ibrar H; Salman M; Khan YH; Mallhi TH; Meyer JC; Godman B; Moore CE
Expert Rev Anti Infect Ther; 2024 Apr; 22(4):229-240. PubMed ID: 38146949
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
10. Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario.
Bassetti M; Brucci G; Vena A; Giacobbe DR
Expert Opin Pharmacother; 2023; 24(15):1679-1684. PubMed ID: 37466425
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.
Kamara IF; Kumar AMV; Maruta A; Fofanah BD; Njuguna CK; Shongwe S; Moses F; Tengbe SM; Kanu JS; Lakoh S; Mansaray AHD; Selvaraj K; Khogali M; Zachariah R
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409687
[TBL] [Abstract][Full Text] [Related]
13. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
15. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
17. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.
Salehi M; Khalili H; Seifi A; Davoudi H; Darazam IA; Jahangard-Rafsanjani Z; Mohammadnejad E; Heydari B; Siahkaly SJM; Tabarsi P; Kalantari S; Menshadi SAD; Babamahmoodi F; Khorvash F; Davarpanah MA; Soltani R; Yaghoobi MH; Anari SAM; Khodadadi J; Aliramezani A; Hantooshzadeh S; Naderi HR; Hajiabdolbaghi M; Elyasi S; Firouzabadi D; Kasgari HA; Roshanzamiri S; Ebrahimpour S
J Clin Pharm Ther; 2022 Dec; 47(12):2140-2151. PubMed ID: 36054303
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.
Martin AJ; Shulder S; Dobrzynski D; Quartuccio K; Pillinger KE
J Pharm Pract; 2023 Apr; 36(2):256-263. PubMed ID: 34291681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
